Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung cancer - Trial UMIN000047162
Access comprehensive clinical trial information for UMIN000047162 through Pure Global AI's free database. This phase not specified trial is sponsored by Kobe University and is currently Not yet recruiting. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000047162
Not yet recruiting
Trial Details
University Hospital Medical Information Network • UMIN000047162
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung cancer
Study Focus
Observational
Sponsor & Location
Kobe University
Japan
Timeline & Enrollment
N/A
May 01, 2022
N/A
ICD-10 Classifications
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung
Data Source
University Hospital Medical Information Network
UMIN000047162
Non-Device Trial